Clinical data | |
---|---|
Other names | Cybutylone |
Legal status | |
Legal status | |
Identifiers | |
| |
PubChem CID | |
UNII | |
Chemical and physical data | |
Formula | C16H21NO3 |
Molar mass | 275.348 g·mol−1 |
3D model (JSmol) | |
| |
|
N-Cyclohexylmethylone (cyputylone) is a substituted cathinone derivative with stimulant effects which has been sold as a designer drug. It was first identified in the United States in 2022.[2][3]
See also
References
- ↑ "§ 54.1-3446. Schedule I." Virginia Law. Retrieved 14 September 2023.
- ↑ CFSRE (2022) N-Cyclohexyl methylone
- ↑ Kuropka P, Zawadzki M, Szpot P (September 2022). "A review of synthetic cathinones emerging in recent years (2019-2022)". Forensic Toxicology. 41 (1): 25–46. doi:10.1007/s11419-022-00639-5. PMC 9476408. PMID 36124107.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.